Los medicamentos agonistas del receptor GLP-1 han transformado el tratamiento de la diabetes tipo 2 y el manejo del peso corporal, pero no todas las personas experimentan los resultados esperados
[DOI] [PMC free article] [PubMed] [Google Scholar] 101.Jamieson PM, Cleasby ME, Kuperman Y, et al
Theyre also great for those with low energy, vitamin deficiencies, or patients undergoing treatments like GLP-1s, HRT, or peptide therapy that can deplete essential nutrients
Weight loss is now the primary motivation, surpassing diabetes management
Ardad RM, Manjappa AS, Dhawale SC, Kumbhar PS, Pore YV (2023) Concurrent oral delivery of non-oncology drugs through solid self-emulsifying system for repurposing in hepatocellular carcinoma
Below 1,200 consistently signals a problem that needs addressing, not celebrating